Bright Minds Biosciences (DRUG) Non-Current Assets (2020 - 2026)

For the quarter ending Q1 2026, Non-Current Assets changed N/A year-over-year to $52778.4, compared with a TTM value of -$4.9 million through Mar 2026, changed N/A, and an annual FY2025 reading of $81359.9, down 5.67% over the prior year.

Bright Minds Biosciences (DRUG) has disclosed Non-Current Assets for 6 consecutive years, with $52778.4 as the latest value for Q1 2026.

  • Non-Current Assets reached $52778.4 in Q1 2026 per DRUG's latest filing, down from $81359.9 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $86249.6 in Q3 2024 and bottomed at -$9.2 million in Q3 2022.
  • Average Non-Current Assets over 5 years is -$2.8 million, with a median of $52778.4 recorded in 2026.
  • Year-over-year, Non-Current Assets soared 101.7% in 2024 and then decreased 5.67% in 2025.
  • Bright Minds Biosciences' Non-Current Assets stood at -$9.2 million in 2022, then skyrocketed by 44.53% to -$5.1 million in 2023, then surged by 101.7% to $86249.6 in 2024, then decreased by 5.67% to $81359.9 in 2025, then tumbled by 35.13% to $52778.4 in 2026.
  • Per Business Quant, the three most recent readings for DRUG's Non-Current Assets are $52778.4 (Q1 2026), $81359.9 (Q3 2025), and $86249.6 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 4.56 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 62,953.78
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 5.83 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 14.75 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 22.66 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 910.24 Mn
10 Bright Minds Biosciences 464.72 Mn 405.19 Mn - 52,778.45

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 52,778.45
Dec 31, 2025 66,100.30
Sep 30, 2025 81,359.87
Jun 30, 2025 93,083.59
Mar 31, 2025 107,682.66
Dec 31, 2024 126,700.29
Sep 30, 2024 86,249.60
Jun 30, 2024 8,828.52
Mar 31, 2024 22,402.91
Dec 31, 2023 35,478.07
Sep 30, 2023 49,539.48
Jun 30, 2023 62,924.84
Mar 31, 2023 75,920.96
Dec 31, 2022 88,957.62
Sep 30, 2022 106,472.68
Sep 30, 2021 1,588.82
Sep 30, 2020 -659,034.07